Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


06.11.2017

1 BMC Gastroenterol
2 Br J Surg
4 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
3 Inflamm Bowel Dis
1 J Crohns Colitis
1 Lancet
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. LU X, Yu Y, Tan S
    p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis.
    BMC Gastroenterol. 2017;17:111.
    PubMed     Text format     Abstract available


    Br J Surg

  2. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
    Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
    Br J Surg. 2017;104:1640-1647.
    PubMed     Text format     Abstract available

  3. DE BUCK VAN OVERSTRAETEN A, Eshuis EJ, Vermeire S, Van Assche G, et al
    Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres.
    Br J Surg. 2017;104:1713-1722.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  4. MORSHEDZADEH N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, et al
    Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4806.
    PubMed     Text format     Abstract available

  5. KAUNITZ JD
    Development of Monoclonal Antibodies: The Dawn of mAb Rule.
    Dig Dis Sci. 2017;62:831-832.
    PubMed     Text format    

  6. TRIADAFILOPOULOS G, Eisenstat S, Dormady S, Sinha R, et al
    When It Rains It Pours: Evolving, Complicated Small Intestinal Crohn's Disease.
    Dig Dis Sci. 2017;62:577-582.
    PubMed     Text format    

  7. REGALIA K, Shelton A, Berry G, Triadafilopoulos G, et al
    Pulmonary Crohn's Disease.
    Dig Dis Sci. 2017;62:64-67.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  8. SKUJA V, Derovs A, Pekarska K, Rudzite D, et al
    Gut colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis.
    Eur J Gastroenterol Hepatol. 2017 Oct 25. doi: 10.1097/MEG.0000000000000989.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  9. ZHANG W, Teng G, Wu T, Tian Y, et al
    Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001252.
    PubMed     Text format     Abstract available

  10. GAWRONSKA A, Banasiuk M, Lachowicz D, Pituch H, et al
    Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001249.
    PubMed     Text format     Abstract available

  11. ANDERSON A, Click B, Ramos-Rivers C, Cheng D, et al
    Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001251.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  12. HARBORD M, Eliakim R, Bettenworth D, Karmiris K, et al
    Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
    J Crohns Colitis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format    


    Lancet

  13. VESELY R, Richardson P
    The switch to infliximab biosimilars.
    Lancet. 2017;389:2266-2268.
    PubMed     Text format    


    PLoS One

  14. SCALDAFERRI F, D'Ambrosio D, Holleran G, Poscia A, et al
    Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
    PLoS One. 2017;12:e0186575.
    PubMed     Text format     Abstract available

  15. FAGAGNINI S, Heinrich H, Rossel JB, Biedermann L, et al
    Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
    PLoS One. 2017;12:e0185193.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. LESHCHINER ES, Rush JS, Durney MA, Cao Z, et al
    Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.
    Proc Natl Acad Sci U S A. 2017;114:11392-11397.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: